A new study suggests oral contraceptives and implants lower risk of ovarian cancer in BRCA1/2 carriers.
Read the full article at the link: https://pubmed.ncbi.nlm.nih.gov/35063280/
Reference: Xia et al. Gynecol Oncol. 2022;164(3):514-521. doi:10.1016/j.ygyno.2022.01.014. PMID: 35063280.